CD8A and neoplasm: Next, we investigated the anti-tumor immune response and found the number of bulk CD8+ T cells in tumor 1 and tumor 2 were not significantly increased with RT or anti-PD-L1 alone while combination therapy demonstrated significant increases in both tumors (Figure S1E).